{
  "main_header": {
    "sid": 116063,
    "name": "Samrat Pharma",
    "stock_name": "Samrat Pharma",
    "full_name": "Samrat Pharmachem Ltd",
    "name_url": "stocks-analysis/samrat-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "196.65",
    "chg": -1.65,
    "chgp": "-0.83%",
    "dir": -1,
    "prev_price": "198.30",
    "mcapval": "63.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530125,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE103E01016",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "3.67 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/samrat-pharma-116063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Samrat Pharmachem reports standalone net loss of Rs 2.04 crore in the March 2026 quarter",
        "link": "https://news.google.com/rss/articles/CBMihAJBVV95cUxOQVJvVHJwRHpqVkYxbXI5R3NRc0NRVnpvU2RDSHBES3NLUFQyOFBUdFByem9WZXdWS25ka0Q4LTBxNXBZaGF6cWJvSWFVOWFzUV95bGd3TGF6US1RQ2hHU3lHMlh2N1prZGdoRENwSjVHUjZqOHlXdVFkeWpSNEpUUElUQ0JxSEtJUHhYOHppT3F6b2RrSzlyTl9FVDNNdjNaanZCZzlFS3BmRG5PeER4ZGhVUHBvYk9ZQVYzdElDdVBHZGlMTGd3M1JUNzJhM0JRSFFVVk1uLVh5NG9WdmJEeEVJUEExZnlra0ltMFhpZG5rMFZzeWJCbVJfa3l4a1ZVUUlYUtIBhAJBVV95cUxOQVJvVHJwRHpqVkYxbXI5R3NRc0NRVnpvU2RDSHBES3NLUFQyOFBUdFByem9WZXdWS25ka0Q4LTBxNXBZaGF6cWJvSWFVOWFzUV95bGd3TGF6US1RQ2hHU3lHMlh2N1prZGdoRENwSjVHUjZqOHlXdVFkeWpSNEpUUElUQ0JxSEtJUHhYOHppT3F6b2RrSzlyTl9FVDNNdjNaanZCZzlFS3BmRG5PeER4ZGhVUHBvYk9ZQVYzdElDdVBHZGlMTGd3M1JUNzJhM0JRSFFVVk1uLVh5NG9WdmJEeEVJUEExZnlra0ltMFhpZG5rMFZzeWJCbVJfa3l4a1ZVUUlYUg?oc=5",
        "imagepath": "",
        "date": "2026-06-01 09:36:58",
        "description": "Samrat Pharmachem reports standalone net loss of Rs 2.04 crore in the March 2026 quarter  Business Standard..."
      }
    ],
    "total": 1,
    "sid": "116063",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/samrat-pharmachem-116063"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Jun-2026",
      "details": "Newspaper Publication of Extract of the Standalone Audited Financial Results for the year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Results For The Quarter And Year Ended 31 March 2026",
      "datetime": "30-May-2026",
      "details": "Audited Financial Results for the quarter and year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
      "datetime": "30-May-2026",
      "details": "The Board considered and adopted the financial results for the quarter and year ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Samrat Pharmachem Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Samrat Pharmachem reports standalone net loss of Rs 2.04 crore in the March 2026 quarter

2026-06-01 09:36:58

Samrat Pharmachem reports standalone net loss of Rs 2.04 crore in the March 2026 quarter Business Standard...

Read More

View All News